Literature DB >> 18019722

Surgical treatment for better prognosis of patients with liver metastases from colorectal cancer.

Nobuhiko Taniai1, Koho Akimaru, Hiroshi Yoshida, Takashi Tajiri.   

Abstract

BACKGROUND/AIMS: Hepatic resection is established as the best available treatment for colorectal cancer metastases to the liver, but the optimal procedure for the resection is now controversial. In this study we retrospectively evaluated the influence of the selection of surgical procedures for hepatic resection in determining the prognostic factors.
METHODOLOGY: A population of 111 patients with liver metastases from colorectal cancer underwent initial and radical hepatic resection. Survival rates as a function of clinical, primary tumor pathologic TNM classification and surgical determinates were examined retrospectively with univariate and multivariate analyses.
RESULTS: The overall, 1-, 3-, 5- and 10-year survival rates were 85.5%, 51.4%, 41.6% and 30.9%, respectively. Patient survival was uncorrelated with any of the following factors: sex, age, temporal relationship, primary tumor site, tumor stage, pathological depth, pathological vascular invasion, pathological lymphatic invasion and pathological lymph node metastases of the primary tumor, maximum diameter of liver lesions, intrahepatic distribution patterns, type of hepatectomy, and number of hepatectomies. However, the number of liver tumors and the tumor-free margins were significantly associated with good prognosis.
CONCLUSIONS: Safe hepatectomy with adequate tumor-free margins leads to a better prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 18019722

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.

Authors:  Jianmin Xu; Xinyu Qin; Jianping Wang; Suzhan Zhang; Yunshi Zhong; Li Ren; Ye Wei; Shaochong Zeng; Deseng Wan; Shu Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-28       Impact factor: 4.553

2.  Can the National Health Service Cancer Plan timeline be applied to colorectal hepatic metastases?

Authors:  Claire Jones; Stephen A Badger; Jane McClements; Lloyd McKie; Tom Diamond; Mark A Taylor
Journal:  Ann R Coll Surg Engl       Date:  2010-03       Impact factor: 1.891

3.  Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.

Authors:  Takanori Ochiai; Taiki Masuda; Masayuki Yagi; Reo Kasai; Takaki Furuyama; Kanako Tsukamoto; Hiromitsu Ito; Kimihiro Igari; Arihiro Aihara; Yoichi Kumagai; Michio Iida; Hajime Odajima; Shinji Tanaka; Shigeki Arii; Shigeru Yamazaki
Journal:  Int Surg       Date:  2012 Jan-Mar

Review 4.  Application of photodynamic therapy for liver malignancies.

Authors:  Heng Zou; Fusheng Wang; Jiang-Jiao Zhou; Xi Liu; Qing He; Cong Wang; Yan-Wen Zheng; Yu Wen; Li Xiong
Journal:  J Gastrointest Oncol       Date:  2020-04

5.  Impact of liver tumor percutaneous radiofrequency ablation on circulating tumor cells.

Authors:  Yang Li; Na Huang; Chunlin Wang; Huanrong Ma; Minyu Zhou; Li Lin; Zhenhua Huang; Li Sun; Min Shi; Wangjun Liao
Journal:  Oncol Lett       Date:  2018-06-25       Impact factor: 2.967

6.  Differential analysis revealing APOC1 to be a diagnostic and prognostic marker for liver metastases of colorectal cancer.

Authors:  Hai-Yu Shen; Fang-Ze Wei; Qian Liu
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

Review 7.  Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations.

Authors:  Franz Sellner
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.